4.8250
-0.0950
(-1.93%)
At close: January 10 at 9:55:00 PM GMT+1
Loading Chart for T0A.MU
DELL
- Previous Close
4.9200 - Open
4.8480 - Bid 4.6500 x --
- Ask 5.0500 x --
- Day's Range
4.7850 - 4.8480 - 52 Week Range
4.2060 - 12.5250 - Volume
0 - Avg. Volume
553 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Feb 26, 2025 - Mar 3, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: T0A.MU
View MorePerformance Overview: T0A.MU
Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
T0A.MU
10.21%
S&P/TSX Composite index
0.60%
1-Year Return
T0A.MU
10.57%
S&P/TSX Composite index
18.10%
3-Year Return
T0A.MU
77.02%
S&P/TSX Composite index
17.47%
5-Year Return
T0A.MU
80.58%
S&P/TSX Composite index
43.70%
Compare To: T0A.MU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
4.8250
-1.93%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
5.15
-1.90%
Mkt Cap EUR 426.451M
Industry Drug Manufacturers—Specialty & Generic
7.09
-1.80%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
7.21
-1.57%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.3220
-3.01%
Mkt Cap EUR 112.486M
Industry Drug Manufacturers—Specialty & Generic
1.1400
-2.56%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
5.35
-0.93%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
5.15
-2.83%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.1858
+13.29%
Mkt Cap EUR 32.885M
Industry Drug Manufacturers—Specialty & Generic
7.08
-2.82%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
7.17
-2.32%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
Statistics: T0A.MU
View MoreValuation Measures
As of 1/9/2025
Market Cap
931.14M
Enterprise Value
1.42B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.82
Price/Book (mrq)
0.73
Enterprise Value/Revenue
1.25
Enterprise Value/EBITDA
4.73
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--